DANVERS, Mass.--(BUSINESS WIRE)--April 18, 2006--ABIOMED, Inc. (NASDAQ: ABMD - News), today announced peer-reviewed data on the IMPELLA® RECOVER® LP 2.5 in the April issue of the American Journal of Cardiology (Volume 97, Issue 7). The study by Dr. J.P.S. Henriques, Cardiologist at the Academic Medical Center in Amsterdam, included 19 patients with high-risk Percutaneous Coronary Interventions (PCI) and who were poor candidates for surgery.
